GH today
$156.09+$1.31 (+0.85%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourBullish
1 hourLeaning Bullish
15 minSymmetric Triangle
5 minLeaning Bullish
Daily trend turns up above $186.03
Key levels
Resistance$186.03
Resistance$168.86
Support$155.00
Support$136.42
Latest news & SEC filings
DealGuardant Health Sets Terms for $500M Convertible Notes Sale
DealGuardant Health proposes $500 million convertible senior notes offering due 2032
ProductGuardant Health launches epigenomic applications for Guardant360 liquid biopsy
AnalystPiper Sandler keeps Overweight rating on Guardant Health
NewsGuardant Health reports journal publication of PRECISION trial data
All GH news →About Guardant Health
Guardant Health is a precision oncology company that develops blood and tissue tests for cancer care. Its offerings include the Guardant360 liquid and tissue tests for therapy selection, the Guardant Reveal test for residual disease and recurrence monitoring, and the Shield test, which screens for colorectal cancer. The company also provides data platforms and research services to biopharmaceutical companies. It serves oncologists, cancer centers, primary care physicians, and biopharmaceutical firms, operating in the United States and internationally.
Based on the company's 10-K filed Feb 19, 2026.
Nasdaq · Healthcare
Guardant Health, Inc. (GH)
What Is the Price Target for GH?
SEPT Low Target
$180.00
SEPT Mid Target
$200.00
SEPT High Target
$225.00
Analyst Consensus
$200.00
Is GH a Buy or Sell Right Now?
Thesis
- •Revenue growing 32.9% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for GH.
Start Free Trial →Is GH Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$200.00
32
Moat Score
NONE
4/9
Piotroski Score
4.6
Altman Z-Score
What Is Smart Money Doing with GH?
Insider Signal
SELLING
0 buys / 10 sells (90d)
Congress Signal
BUYING
2 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| MIGNONE ROBERTO | director | Buy | 264 | - | Oct 21, 2026 |
| Azar Alex M II | director | Sale | 69 | $11K | Oct 14, 2026 |
| Azar Alex M II | director | Buy | 137 | - | Oct 12, 2026 |
| MIGNONE ROBERTO | director | Buy | 264 | - | Sep 21, 2026 |
| Hidalgo Medina Manuel | director | Buy | 232 | - | Sep 17, 2026 |
| Azar Alex M II | director | Sale | 826 | $145K | Sep 16, 2026 |
| Azar Alex M II | director | Buy | 1,651 | - | Sep 12, 2026 |
| Eltoukhy Helmy | director officer | Sale | 25,000 | - | Aug 26, 2026 |
| Eltoukhy Helmy | director officer | Sale | 30,000 | - | Aug 26, 2026 |
| MIGNONE ROBERTO | director | Buy | 264 | - | Aug 21, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →GH Growth Story
Revenue YoY
32.9%
3yr Revenue CAGR
29.8%
EPS Growth YoY
6.74%
FCF Growth YoY
15.2%
Revenue Trend
ACCELERATING
Dark Pool Trades for GH
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for GH, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 15:50:01 | $156.38 | 17,900 | $$2.8M | BUY |
| 15:47:53 | $156.70 | 17,200 | $$2.7M | BUY |
| 15:35:52 | $155.45 | 17,700 | $$2.8M | SELL |
| 15:33:24 | $155.71 | 10,000 | $$1.6M | BUY |
| 15:32:00 | $155.47 | 9,000 | $$1.4M | BUY |
5 dark pool trades shown · $$11.2M preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for GH
PREVIEWSEPT Investing provides real-time options flow tracking for GH, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| PUT | $160 | Nov 20 | 8 | $$840 | 1 | SWEEP |
| PUT | $160 | Nov 20 | 8 | $$840 | 1 | SWEEP |
| PUT | $160 | Nov 20 | 8 | $$840 | 1 | SWEEP |
| PUT | $160 | Nov 20 | 8 | $$840 | 1 | SWEEP |
| PUT | $160 | Nov 20 | 8 | $$840 | 1 | SWEEP |
5 options trades shown · 0% calls
Unusual activity, GEX levels, max pain, and dealer positioning
What Traders Are Saying About GH
2 postsSEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for GH. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.
Zone Setup — $GH (Guardant Health, Inc.) Price: $170.69 | Zone: $160.01 — $176.58 Conviction: HIGH | Analyst upside: +13.1% Near resistance (64% of range) — breakout watch. Strong positive news (12+...
Zone Setup -- $GH (Guardant Health, Inc.) Price: $130.64 | Zone: $124.91 to $133.34 Conviction: HIGH | Analyst upside: +18.6% Near resistance (68% of range) — breakout watch. Strong positive news (1...
Join 3,500+ traders discussing GH in real-time
Trade ideas, setups, dark pool alerts, and AI-powered analysis
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Guardant Health, Inc. (GH) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (4 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →GH — frequently asked questions
What is GH stock price today?
Guardant Health, Inc. (GH) is at $156.09, up 0.85% (+$1.31) at the Nov 12, 2026 close.
Why is GH stock moving today?
Latest GH news — Nov 12, 2026: Guardant Health Sets Terms for $500M Convertible Notes Sale · Nov 11, 2026: Guardant Health proposes $500 million convertible senior notes offering due 2032
Why did GH stock move on Oct 27, 2026?
Guardant Health shares rose 2.49% to close at $178.06, trading between a low of $172.60 and a high of $178.69 on volume of about 1.43 million shares. The move followed BTIG's decision to raise its valuation estimate and price target for the diagnostics company to $210 while keeping a Buy rating.
What is the GH price target?
The average analyst price target for GH is $200.00, ranging from $180 to $225, based on 18 analysts. Latest: BTIG maintains on Oct 27, 2026.
What do analysts rate GH?
Analyst ratings for GH: 1 Buy, 39 Hold, 0 Sell — consensus Hold.
Did GH beat earnings?
GH last reported on Jul 30, 2026: EPS -$0.90 vs -$0.76 expected — a miss of 18.1%.
Does GH pay a dividend?
GH does not currently pay a dividend.
How much debt does GH have?
Guardant Health, Inc. reported $1.5B of debt and $1.1B of cash (Jun 30, 2026).
What are GH support and resistance levels?
Support: $155.00, $136.42, $125.00. Resistance: $168.86, $186.03.
What are insiders doing with GH?
Insider activity: SELLING, 0 buys and 10 sells in the last 90 days.
What is the latest news on GH?
Nov 12, 2026: Guardant Health Sets Terms for $500M Convertible Notes Sale · Nov 11, 2026: Guardant Health proposes $500 million convertible senior notes offering due 2032 · Nov 11, 2026: Guardant Health launches epigenomic applications for Guardant360 liquid biopsy